# DermLink

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dermlink

- Industry: Healthcare
- Headquarters: Menlo Park, US
- Website: www.dermlink.md
- Latest round: Seed (Apr 4, 2012)
- Investors on record: 6

## About

DermLink is a teledermatology service providing quick and convenient skin assessments through a digital platform, enabling clients to receive professional diagnoses and treatment plans efficiently.Founded in 2011, DermLink is based in Menlo Park, US and specializes in teledermatology services. The company has undergone three notable deals, with the most recent financing completed on August 1, 2014. Information about its founders or specific changes in business strategy is not publicly available.DermLink offers a teledermatology service that enables users to receive quick and convenient skin assessments without the need for in-person consultations. The core product is a digital platform where clients submit images of skin lesions or rashes and receive a professional diagnosis, treatment plan, and prescription from licensed dermatologists, typically within a day. This service caters to a diverse clientele, including busy professionals, students, and individuals traveling who require prompt dermatological care. DermLink primarily operates in markets such as the United States, Canada, and parts of Europe, focusing on those seeking efficient and accessible dermatology solutions. The platform aims to alleviate common skin concerns, especially for individuals with a history of skin conditions or cancer, thereby simplifying the healthcare process.DermLink generates revenue through a fee-for-service structure, where clients pay for individual consultations and assessments via the online platform. Each transaction involves users submitting their skin-related queries and receiving a timely diagnosis and treatment recommendation, which forms the core of their service offering. The pricing model includes fees for consultations that vary based on the complexity of the case. DermLink's services are marketed as both direct-to-consumer and through business-to-business partnerships, with potential collaborations involving healthcare providers and organizations seeking to enhance their patient care offerings. The company’s flagship service, DermLink™, underscores its commitment to offering efficient dermatological solutions, creating a streamlined transaction process for end-users.DermLink's future growth strategy includes the design and launch of new products aimed at expanding its teledermatology services. The company plans to explore additional markets, particularly in North America and Europe, to increase its user base. The financing completed on August 1, 2014, will be leveraged to support these initiatives, although specific deployment details are not publicly disclosed.

## Funding rounds

- Seed, Apr 4, 2012 — Stanford University, Ulu Ventures, StartX, Stanford Angels & Entrepreneurs, Healthbox, LLC, Stanford Health Care

## Investors

- Stanford University — Seed
- Ulu Ventures (https://capitalatlas.ai/funds/ulu-ventures) — Seed
- StartX — Seed
- Stanford Angels & Entrepreneurs (https://capitalatlas.ai/funds/stanford-angels-entrepreneurs) — Seed
- Healthbox, LLC — Seed
- Stanford Health Care — Seed